| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
228 |
| issn |
0161-2840
1096-4673 |
| issueIdentifier |
2 |
| pageRange |
223-228 |
| publicationName |
Issues in Mental Health Nursing |
| startingPage |
223 |
| bibliographicCitation |
Tobin M. Psychopharmacology column: why choose selegiline transdermal system for refractory depression? Issues Ment Health Nurs. 2007 Feb;28(2):223–8. doi: 10.1080/01612840601096461. PMID: 17365170. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5c9406ba2ae6e83ad4fdf98bf34d4da |
| date |
200701 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/17365170
https://doi.org/10.1080/01612840601096461 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0161-2840
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4399
https://portal.issn.org/resource/ISSN/1096-4673 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Psychopharmacology column: why choose selegiline transdermal system for refractory depression? |
| discusses |
http://id.nlm.nih.gov/mesh/M0019601
http://id.nlm.nih.gov/mesh/M0014029
http://id.nlm.nih.gov/mesh/M0001384
http://id.nlm.nih.gov/mesh/M0022194 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D012642Q000008
http://id.nlm.nih.gov/mesh/D003865Q000451
http://id.nlm.nih.gov/mesh/D000928Q000008
http://id.nlm.nih.gov/mesh/D008996Q000008 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D003865Q000188
http://id.nlm.nih.gov/mesh/D000279
http://id.nlm.nih.gov/mesh/D008996Q000009
http://id.nlm.nih.gov/mesh/D012642Q000009
http://id.nlm.nih.gov/mesh/D012307
http://id.nlm.nih.gov/mesh/D004347
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000928Q000009
http://id.nlm.nih.gov/mesh/D016032
http://id.nlm.nih.gov/mesh/D014439Q000009 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26757
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11392 |